FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Woodcock Optimistic on Startlingly Better Therapies

[ Price : $8.95]

CDER director Janet Woodcock says she is so optimistic that the 40 years of biomedical science and the war on cancer will be produ...

FDA Dodges Bullet in House/Senate Funding Agreement

[ Price : $8.95]

FDA dodges a funding bullet as House and Senate conferees agree to follow the Senates version of the agencys FY 2012 appropriation...

Sen. Franken Introduces Device Reform Bill

[ Price : $8.95]

Sen. Al Franken (D-MN) introduces the Patient Access to Medical Innovation Act to get innovative medical devices to market more qu...

Distribution of Pennsaid Samples Stopped

[ Price : $8.95]

FDA asks Mallinckrodt to stop distributing 15 mL sample bottles of Pennsaid due to reports of improper administration by patients.

Bill Would Limit Commissioners Terms, Boost Innovation

[ Price : $8.95]

Sen. Kay Hagan proposes legislation to set a fixed six-year term for the FDA commissioner and create new drug approval pathways.

LASIK Facility Warned About MDR Violations

[ Price : $8.95]

FDA warns Laser Eye Care of California about medical device reporting violations at its laser surgery facility.

Consumers Union Wants Medical Device Safety Reforms

[ Price : $8.95]

Consumers Union calls on Congress to strengthen, rather than weaken, medical device safety requirements.

Geron Focusing on Cancer, Ending Spinal Cord Trial

[ Price : $8.95]

Geron says it is ending enrollment in its stem cell spinal cord injury trial to concentrate on two oncology drugs.

FDA Says Intellipharmaceutics Canadian Facility is Acceptable

[ Price : $8.95]

FDA has given acceptable status to an Intellipharmaceutics drug manufacturing facility.

Latest FDA Warning Letters

[ Price : $8.95]

In its latest batch of Warning Letters, FDA cites Leslie Diaz, Laser Eye Care of CA, Medical Compression Systems, Rainbow Ltd dba ...